From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy

Molecular Therapy Advances · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles